Dynavax Technologies (DVAX) Reports Break-Even Earnings for Q4
https://www.zacks.com/stock/news/2230460/dynavax-technologies-dvax-reports-break-even-earnings-for-q4?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2230460
Feb 22, 2024 - Dynavax Technologies (DVAX) delivered earnings and revenue surprises of 100% and 1%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2270038/myriad-genetics-mygn-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270038
May 07, 2024 - Myriad (MYGN) delivered earnings and revenue surprises of 90.91% and 4.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
0
Pages: 12
<Page 2